Loading insider details...
Latest Form 4 (Jun 23, 2026): Grant/Award of 95,400 ALLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 95,400 | n/a |
| May 4, 2026 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $221.0K |
| Apr 2, 2026 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $199.6K |
| Mar 3, 2026 | Vir Biotechnology, Inc. (VIR) | Sale | 21,800 | $207.2K |
| Feb 26, 2026 | Vir Biotechnology, Inc. (VIR) | Exercise/Conversion | 42,377 | $62.9K |
| Feb 3, 2026 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $169.7K |
| Jan 5, 2026 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $130.4K |
| Dec 3, 2025 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $132.1K |
| Nov 4, 2025 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $124.0K |
| Oct 2, 2025 | Vir Biotechnology, Inc. (VIR) | Sale | 22,000 | $128.4K |